Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51,136,131
-
Total 13F shares
-
29,584,479
-
Share change
-
-347,658
-
Total reported value
-
$1,212,076,877
-
Put/Call ratio
-
148%
-
Price per share
-
$40.97
-
Number of holders
-
178
-
Value change
-
-$13,179,927
-
Number of buys
-
85
-
Number of sells
-
62
Institutional Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q4 2019
As of 31 Dec 2019 REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) had 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,584,479 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Redmile Group, LLC, STATE STREET CORP, JPMORGAN CHASE & CO, WS MANAGEMENT LLLP, DIMENSIONAL FUND ADVISORS LP, UBS Group AG, PERCEPTIVE ADVISORS LLC, and CREDIT SUISSE AG/.
This table shows 178 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.